Published in JAMA on September 12, 1990
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol (1994) 4.95
Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China. Infect Immun (1992) 4.02
Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev (2000) 3.69
Characterization of the gene cassette required for biosynthesis of the (alpha1-->6)-linked N-acetyl-D-mannosamine-1-phosphate capsule of serogroup A Neisseria meningitidis. J Bacteriol (1998) 1.83
Smoking, the environment and meningococcal disease: a case control study. Epidemiol Infect (1994) 1.62
Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev (2006) 1.53
Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis. Vaccine (2009) 1.52
Meningococcal meningitis and carriage in western Zaire: a hypoendemic zone related to climate? Epidemiol Infect (1995) 1.50
Weather conditions and cerebrospinal meningitis in Benin (Gulf of Guinea, West Africa). Eur J Epidemiol (1997) 1.45
Phenotypic and molecular characterization of serogroup C Neisseria meningitidis associated with an outbreak in Bahia, Brazil. Enferm Infecc Microbiol Clin (2011) 1.32
Epidemiological profile of meningococcal disease in the United States. Clin Infect Dis (2010) 1.31
Meningococcal lipopolysaccharides: virulence factor and potential vaccine component. Microbiol Rev (1993) 1.26
Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ (2006) 1.21
Meningococcal disease and the complement system. Virulence (2013) 1.19
Epidemiological features of invasive Kingella kingae infections and respiratory carriage of the organism. J Clin Microbiol (2002) 1.12
The immunopathogenesis of meningococcal disease. J Clin Pathol (2003) 1.07
Antibiotic prescribing during an outbreak of meningococcal disease. Epidemiol Infect (1996) 1.07
Pathogenesis, Therapy, and Prevention of Meningococcal Sepsis. Curr Infect Dis Rep (2002) 1.00
Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules. Infect Immun (2009) 0.99
Respiratory syncytial virus infection and meningococcal disease. Epidemiol Infect (1996) 0.98
Trends in meningococcal disease in the United States military, 1971-2010. Emerg Infect Dis (2012) 0.96
Hajj-related Neisseria meningitidis serogroup w135 in Mauritius. Emerg Infect Dis (2002) 0.93
Effect of respiratory syncytial virus infection on binding of Neisseria meningitidis and Haemophilus influenzae type b to a human epithelial cell line (HEp-2). Epidemiol Infect (1993) 0.91
Childhood pyogenic meningitis: clinical and investigative indicators of etiology and outcome. J Natl Med Assoc (2007) 0.90
Carriage of Neisseria species in communities with different rates of meningococcal disease. Can J Infect Dis (1992) 0.90
Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989-1996. Am J Public Health (1999) 0.89
Coinfection with influenza B virus does not affect association of Neisseria meningitidis with human nasopharyngeal mucosa in organ culture. Infect Immun (1999) 0.87
Incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis belt: a systematic review and meta-analysis. PLoS One (2015) 0.86
Spatial dynamics of meningococcal meningitis in Niger: observed patterns in comparison with measles. Epidemiol Infect (2011) 0.86
Modelling seasonal variations in the age and incidence of Kawasaki disease to explore possible infectious aetiologies. Proc Biol Sci (2012) 0.83
When we sneeze, does the immune system catch a cold? BMJ (1991) 0.83
Meningococcal Vaccinations. Infect Dis Ther (2016) 0.82
Meningococcal disease serogroup C. Risk Manag Healthc Policy (2012) 0.79
Clinical and laboratory evidence for Neisseria meningitidis biofilms. Future Microbiol (2009) 0.79
Potential Impact of Co-Infections and Co-Morbidities Prevalent in Africa on Influenza Severity and Frequency: A Systematic Review. PLoS One (2015) 0.79
Meningococcal infections and the general practitioner. Br J Gen Pract (1992) 0.75
Virus-associated apoptosis of blood neutrophils as a risk factor for invasive meningococcal disease. J Clin Pathol (2013) 0.75
Disease-associated Neisseria meningitidis isolates inhibit wound repair in respiratory epithelial cells in a type IV pilus-independent manner. Infect Immun (2014) 0.75
State-based surveillance to determine trends in meningococcal disease. Public Health Rep (2009) 0.75
Mycoplasma and epidemic group A meningococcal meningitis. JAMA (1991) 0.75
Pasteurized milk as a vehicle of infection in an outbreak of listeriosis. N Engl J Med (1985) 11.94
Epidemic listeriosis--evidence for transmission by food. N Engl J Med (1983) 11.72
Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med (1980) 7.85
Listeriosis. JAMA (1989) 7.06
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
Epidemiology of human listeriosis. Clin Microbiol Rev (1991) 5.21
Public health policy for preventing violence. Health Aff (Millwood) (1993) 5.17
Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA (1993) 4.63
Direct detection of Mycobacterium tuberculosis in sputum by polymerase chain reaction and DNA hybridization. J Clin Microbiol (1993) 4.13
Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease. J Infect Dis (1984) 3.91
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA (1999) 3.69
Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA (1993) 3.31
Does antenatal care make a difference to safe delivery? A study in urban Uttar Pradesh, India. Health Policy Plan (1999) 3.18
Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann Intern Med (1982) 3.12
Toxic-shock syndrome not associated with menstruation. A review of 54 cases. Lancet (1982) 3.10
Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA (1991) 3.09
Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet (1989) 3.09
The carrier state: Neisseria meningitidis. J Antimicrob Chemother (1986) 3.00
Analysis of clinical and food-borne isolates of Listeria monocytogenes in the United States by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Appl Environ Microbiol (1990) 2.90
Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA (1985) 2.87
Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med (1980) 2.85
Role of foods in sporadic listeriosis. I. Case-control study of dietary risk factors. The Listeria Study Group. JAMA (1992) 2.82
Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis (1990) 2.80
Validation of Legionella pneumophila indirect immunofluorescence assay with epidemic sera. J Clin Microbiol (1981) 2.56
Investigation of an outbreak of listeriosis: new hypotheses for the etiology of epidemic Listeria monocytogenes infections. J Infect Dis (1989) 2.42
Association of sporadic listeriosis with consumption of uncooked hot dogs and undercooked chicken. Lancet (1988) 2.42
Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet (1985) 2.39
Reactivity of serum from patients with suspected legionellosis against 29 antigens of legionellaceae and Legionella-like organisms by indirect immunofluorescence assay. J Infect Dis (1983) 2.28
Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med (1986) 2.26
Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins. JAMA (1985) 2.16
Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. The Listeria Study Group. JAMA (1992) 2.15
Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med (1982) 2.14
Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. J Clin Microbiol (2001) 2.12
Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. J Infect Dis (1998) 2.11
Global epidemiology of meningococcal disease. Clin Microbiol Rev (1989) 2.11
Detection of enteroviruses and rhinoviruses in clinical specimens by PCR and liquid-phase hybridization. J Clin Microbiol (1995) 2.10
Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis. Lancet (1988) 2.06
Group A meningococcal carriage in travelers returning from Saudi Arabia. JAMA (1988) 2.06
Epidemiologic aspects of legionellosis. Epidemiol Rev (1979) 2.03
Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. JAMA (1985) 1.91
Infection caused by Francisella philomiragia (formerly Yersinia philomiragia). A newly recognized human pathogen. Ann Intern Med (1989) 1.89
Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis (1997) 1.86
The epidemiology of listeriosis in the United States--1986. Listeriosis Study Group. Am J Epidemiol (1991) 1.84
Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis (1990) 1.77
Risk factors for primary invasive Haemophilus influenzae disease: increased risk from day care attendance and school-aged household members. J Pediatr (1985) 1.76
Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med (1983) 1.75
Trans-isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. J Clin Microbiol (1984) 1.70
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
Asymptomatic infection and risk factors for leptospirosis in Nicaragua. Am J Trop Med Hyg (2001) 1.66
Rapid diagnosis of Legionnaires' disease by direct immunofluorescent staining. Ann Intern Med (1979) 1.65
Outbreak of neonatal listeriosis associated with mineral oil. Pediatr Infect Dis J (1991) 1.64
Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis. JAMA (1993) 1.63
Epidemiology of pertussis, Atlanta, 1977. J Pediatr (1981) 1.62
A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J Infect Dis (1995) 1.61
Cardiovascular disease risk factors are lower in African-American vegans compared to lacto-ovo-vegetarians. J Am Coll Nutr (1998) 1.61
Sporadic legionellosis in the United States: the first thousand cases. Ann Intern Med (1981) 1.60
An outbreak of Pontiac fever related to whirlpool use, Michigan 1982. JAMA (1985) 1.58
Childhood upper respiratory tract infections: to what degree is incidence affected by day-care attendance? Pediatrics (1987) 1.57
A randomised trial of a Haemophilus influenzae type b conjugate vaccine in a developing country for the prevention of pneumonia--ethical considerations. Int J Tuberc Lung Dis (1999) 1.51
Legionnaires' disease in patients with associated serious disease. Ann Intern Med (1979) 1.50
Detection of chlamydiosis in a shipment of pet birds, leading to recognition of an outbreak of clinically mild psittacosis in humans. Clin Infect Dis (1998) 1.49
Diphtheria in the United States, 1971-81. Am J Public Health (1985) 1.44
A point-source foodborne listeriosis outbreak: documented incubation period and possible mild illness. J Infect Dis (1994) 1.43
Epidemic meningococcal disease in Nairobi, Kenya, 1989. The Kenya/Centers for Disease Control (CDC) Meningitis Study Group. J Infect Dis (1992) 1.43
Geocoding and linking data from population-based surveillance and the US Census to evaluate the impact of median household income on the epidemiology of invasive Streptococcus pneumoniae infections. Am J Epidemiol (1998) 1.43
Active surveillance for toxic shock syndrome in the United States, 1986. Rev Infect Dis (1989) 1.41
Risk factors for deaths in children under 5 years old in Bagamoyo district, Tanzania. Trop Med Parasitol (1992) 1.40
Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS (2001) 1.40
Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. J Pediatr (1986) 1.40
[The value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and relapse diagnosis of colorectal tumors]. Rofo (1992) 1.38
Sporadic community-acquired Legionnaires' disease in the United States. A case-control study. Ann Intern Med (1979) 1.37
Epidemic group C meningococcal meningitis in Upper Volta, 1979. Bull World Health Organ (1983) 1.35
Mount St. Helens eruptions: the acute respiratory effects of volcanic ash in a North American community. Arch Environ Health (1983) 1.34
Meningococcal disease in the United States--1986. Meningococcal Disease Study Group. J Infect Dis (1991) 1.34
From the center for disease control. Epidemiology of pneumococcal serotypes in the United States, 1978--1979. J Infect Dis (1980) 1.32
Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model. Infect Immun (1985) 1.30
Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States. Rev Infect Dis (1981) 1.30
A large outbreak of epidemic keratoconjunctivitis: problems in controlling nosocomial spread. J Infect Dis (1989) 1.28
Pneumococcal vaccine: to use or not. JAMA (1981) 1.27
Plasmid profile, serogrouping, and auxotyping of Neisseria gonorrhoeae isolates from Africa. Br J Vener Dis (1983) 1.27
Vaccine prevention of Haemophilus influenzae type b disease: past, present and future. Pediatr Infect Dis (1986) 1.27
An outbreak of Yersinia enterocolitica O:8 infections associated with pasteurized milk. J Infect Dis (2000) 1.26
Nosocomial legionellosis, Paris, France. Evidence for transmission by potable water. Am J Med (1985) 1.26
Correlation of auxotype and protein I type with expression of disease due to Neisseria gonorrhoeae. J Infect Dis (1985) 1.24
A cluster of meningococcal disease on a school bus following epidemic influenza. Arch Intern Med (1991) 1.23
Pertussis in the United States, 1979: a look at vaccine efficacy. J Infect Dis (1981) 1.21
Invasive Haemophilus influenzae disease: a population-based evaluation of the role of capsular polysaccharide serotype. Haemophilus Influenzae Study Group. J Infect Dis (1992) 1.19
A rabbit model of toxic shock syndrome: clinicopathological features. J Infect (1984) 1.19
Listeriosis in the United States: 1980-1982. Arch Intern Med (1988) 1.18
Epidemiology and clinical spectrum of Brazilian purpuric fever. Brazilian Purpuric Fever Study Group. J Clin Microbiol (1989) 1.18
Clinical significance of Lancefield groups L-T streptococci isolated from blood and cerebrospinal fluid. J Infect Dis (1976) 1.16
The Vermont epidemic of Legionnaires' disease. Ann Intern Med (1979) 1.16
Pathologic findings in twelve fatal cases of toxic shock syndrome. Ann Intern Med (1982) 1.15
Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization. J Infect Dis (1993) 1.14
Commercial latex agglutination tests for detection of Haemophilus influenzae type b and Streptococcus pneumoniae antigens in patients with bacteremic pneumonia. J Clin Microbiol (1987) 1.13
Fatal nosocomial Legionnaires' disease: clinical and epidemiologic characteristics. Ann Intern Med (1979) 1.13